Skip to main content
. 2021 Feb 2;35(2):912–924. doi: 10.1111/jvim.16021

TABLE 2.

Analyte‐specific unit and percentage annual change intervals

Analyte N Annual change interval (analyte‐specific units) Annual change interval (%)
Median (range) Lower limit (90% CI) Upper limit (90% CI) Median (range) Lower limit (90% CI) Upper limit (90% CI)
Albumin (g/dL) 189/190* 0.0 (−0.8, 0.6) −0.4 (−0.8, −0.3) 0.5 (0.3, 0.6) 0 (−20, 18) −11 (−20, −8) 14 (10, 18)
ALP (U/L) 188/190* −3.0 (−43, 90) −30 (−43, −20) 19 (13, 90) −13 (−61, 163) −52 (−61, −48) 74 (43, 163)
ALT (U/L) 190/190 −1 (−119, 170) −46 (−102, −18) 59 (22, 92) −3 (−78, 271) −60 (−70, −39) 149 (67, 264)
Amylase (U/L) 189/190* −9 (−567, 1071) −263 (−567, −217) 397 (269, 1071) −1 (−52, 179) −39 (−52, −34) 64 (44, 179)
AST (U/L) 190/190 0 (−31, 26) −19 (−27, −12) 12 (10, 17) 0 (−70, 123) −47 (−55, −36) 55 (50, 94)
BUN (mg/dL) 190/190 0 (−12, 12) −8 (−9, −7) 6 (5, 8) 0 (−50, 64) −40 (−48, −33) 49 (42, 58)
Calcium (mg/dL) 189/190* 0.0 (−1.8, 1.0) −1.0 (−1.8, −0.8) 0.7 (0.5, 1.0) 0 (−18, 10) −9 (−18, −7) 7 (5, 10)
Chloride (mmol) 189/190* 0 (−7, 7) −4 (−7, −4) 5 (3, 7) 0 (−6, 6) −4 (−6, −3) 5 (3, 6)
Cholesterol (mg/dL) 189/190* 7 (−157, 166) −86 (−157, −75) 95 (88, 166) 3 (−36, 83) −30 (−36, −25) 43 (33, 83)
Creatine kinase (U/L) 190/190 −1.5 (−438, 259) −156 (−393, −92) 137 (97, 244) −1.4 (−91, 323) −73 (−82, −61) 179 (108, 213)
Creatinine (mg/dL) 190/190 0.0 (−1.3, 0.3) −0.3 (−1.2, −0.2) 0.3 (0.2, 0.3) 0 (−100, 43) −28 (−100, −21) 28 (22, 33)
GGT (U/L) 190/190 0 (−9, 8) −5 (−7, −3) 6 (4, 7) 0 (−83, 600) −66 (−80, −50) 323 (150, 500)
Globulin (g/dL) 189/190* 0.1 (−0.7, 0.9) −0.5 (−0.7, −0.4) 0.8 (0.6, 0.9) 4 (−23, 45) −16 (−23, −12) 34 (27, 45)
Glucose (mg/dL) 189/190* −2 (−36, 41) −26 (−36, −20) 25 (17, 40) −2 (−38, 84) −26 (−38, −20) 32 (21, 84)
Lipase (U/L) 82/190* 12 (−314, 349) −190 (−225, −145)^ 214 (170, 251)^ 5 (−68, 306) −46 (−52, −38)^ 128 (87, 292)^
Magnesium (mg/dL) 189/190* 0.0 (−0.3, 1.0) −0.2 (−0.3, −0.1) 0.3 (0.2, 1.0) 0 (−16, 67) −11 (−16, −7) 22 (14, 67)
Potassium (mmol) 189/190* 0 (−0.8, 0.9) −0.6 (−0.8, −0.5) 0.5 (0.4, 0.9) 0 (−16, 22) −14 (−16, −11) 13 (9, 22)
Phosphate (mg/dL) 189/190* −0.3 (−2.2, 2.8) −1.9 (−2.2, −1.5) 1.3 (0.7, 2.8) −7 (−38, 76) −36 (−38, −33) 41 (23, 76)
Sodium (mmol) 189/190* 0 (−5, 9) −4 (−5, −3) 4 (4, 9) 0 (−3, 6) −3 (−3, −2) 3 (3, 6)
Total bilirubin (mg/dL) 189/190* 0 (−0.2, 0.2) −0.1 (−0.2, −0.1) 0.1 (0.1, 0.2) 0 (−67, 200) −50 (−67, −33) 100 (100, 200)
Total protein (g/dL) 189/190* 0.1 (−0.8, 1.2) −0.6 (−0.8, −0.4) 0.9 (0.7, 1.2) 2 (−12, 21) −9 (−12, −6) 16 (12, 21)
Total T4 (μg/dL) 190/190 0 (−1.6, 2.4) −1.1 (−1.3, −0.9) 1.3 (1.0, 1.6) 0 (−88, 200) −53 (−62, −47) 126 (82, 185)
Triglycerides (mg/dL) 189/190* 1 (−227, 126) −60 (−227, −24) 80 (60, 126) 2 (−79, 286) −50 (−79, −36) 183 (129, 286)

Note: Annual changes were calculated by subtracting the result for year 2 from the result for year 1, so positive changes are an increase and negative changes a decrease in analyte concentrations between annual health checks. * indicates data missing from at least one reference individual. Reasons for missing data could not be retrieved for individual dogs; ^ indicates calculation using the robust method with 90% CI after Box‐Cox transformation. CI, confidence interval.

HHS Vulnerability Disclosure